ArticleFrontiers in immunology2022

Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination.

Maria Gonzalez-Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.